首页> 外文OA文献 >Kinetic modelling of [(11)C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis
【2h】

Kinetic modelling of [(11)C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis

机译:[(11)C] pBR28对18 kDa易位蛋白pET数据的动力学建模:使用XBD173和组织分析对大脑血管建模进行验证研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 18 kDa translocator protein (TSPO) is a marker of microglia activation in the central nervous system and represents the main target of radiotracers for the in vivo quantification of neuroinflammation with positron emission tomography (PET). TSPO PET is methodologically challenging given the heterogeneous distribution of TSPO in blood and brain. Our previous studies with the TSPO tracers [11C]PBR28 and [11C]PK11195 demonstrated that a model accounting for TSPO binding to the endothelium improves the quantification of PET data. Here, we performed a validation of the kinetic model with the additional endothelial compartment through a displacement study. Seven subjects with schizophrenia, all high-affinity binders, underwent two [11C]PBR28 PET scans before and after oral administration of 90 mg of the TSPO ligand XBD173. The addition of the endothelial component provided a signal compartmentalization much more consistent with the underlying biology, as only in this model, the blocking study produced the expected reduction in the tracer concentration of the specific tissue compartment, whereas the non-displaceable compartment remained unchanged. In addition, we also studied TSPO expression in vessels using 3D reconstructions of histological data of frontal lobe and cerebellum, demonstrating that TSPO positive vessels account for 30% of the vascular volume in cortical and white matter.
机译:18 kDa转运蛋白(TSPO)是中枢神经系统中小胶质细胞活化的标志物,并且是放射性示踪剂的主要靶标,可通过正电子发射断层扫描(PET)进行体内神经炎症定量。鉴于TSPO在血液和大脑中的分布不均,因此TSPO PET在方法上具有挑战性。我们以前使用TSPO示踪剂[11C] PBR28和[11C] PK11195进行的研究表明,考虑TSPO与内皮结合的模型可改善PET数据的定量。在这里,我们通过位移研究对带有额外内皮区室的动力学模型进行了验证。七个精神分裂症患者(均为高亲和力结合剂)在口服90μgTSPO配体XBD173之前和之后均进行了两次[11C] PBR28 PET扫描。内皮成分的添加提供了与基础生物学更加一致的信号区分开,因为仅在该模型中,阻断研究产生了特定组织区的示踪剂浓度的预期降低,而不可移位区保持不变。此外,我们还使用额叶和小脑组织学数据的3D重建研究了血管中TSPO的表达,证明TSPO阳性血管占皮质和白质中血管体积的30%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号